tiprankstipranks
Advertisement
Advertisement
Castle Biosciences: Strong Assay Momentum and Underpenetrated Market Support Buy Rating and $50 Price Target
PremiumRatingsCastle Biosciences: Strong Assay Momentum and Underpenetrated Market Support Buy Rating and $50 Price Target
2M ago
Castle Biosciences price target raised to $44 from $41 at Baird
Premium
The Fly
Castle Biosciences price target raised to $44 from $41 at Baird
2M ago
Castle Biosciences reports Q4 EPS (8c), consensus (26c)
Premium
The Fly
Castle Biosciences reports Q4 EPS (8c), consensus (26c)
2M ago
Castle Biosciences Reports Strong Preliminary 2025 Revenue Growth
PremiumCompany AnnouncementsCastle Biosciences Reports Strong Preliminary 2025 Revenue Growth
3M ago
Castle Biosciences: Broad-Based Test Growth, Strengthening Cash Generation, and Pipeline Upside Support Reiterated Buy and $50 Target
Premium
Ratings
Castle Biosciences: Broad-Based Test Growth, Strengthening Cash Generation, and Pipeline Upside Support Reiterated Buy and $50 Target
3M ago
Castle Biosciences price target raised to $52 from $35 at Lake Street
Premium
The Fly
Castle Biosciences price target raised to $52 from $35 at Lake Street
3M ago
Castle Biosciences announces new data on DecisionDx-UM, PRAME
PremiumThe FlyCastle Biosciences announces new data on DecisionDx-UM, PRAME
4M ago
Castle Biosciences price target raised to $50 from $38 at BTIG
Premium
The Fly
Castle Biosciences price target raised to $50 from $38 at BTIG
4M ago
Castle Biosciences announces publication of new SRMA on TissueCypher
Premium
The Fly
Castle Biosciences announces publication of new SRMA on TissueCypher
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100